Clearant was founded in 1999 to develop and commercialize a promising pathogen inactivation technology — the Clearant Process® — for the biological products market.

Today, Clearant's experts in the fields of sterilization, biological science and regulatory affairs are actively using Clearant's core technology plus its specific applications — the Clearant Process® — to clients dedicated to a pathogen inactivation solution designed to be effective in substantially reducing all types of pathogens.

Clearant, Inc. is a public company with offices in Los Angeles, California, and processing facility in Mundelein, Illinois.

Management Team
Clearant's management team of leading scientists, biopharmaceutical and business executives.

Jon Garfield - CEO
Susan Etzel - Controller
Steve Burns - Director: Technology Transfer and Manufacturing
Carlo Brigola - Director of Sales
Cindy Atkins - Director of Sales
Shahrzad Ghaemmaghami - Product Distribution Manager
David Naughton - Sterilization Services Manager
Dr. Phil Davidson - Advisor Go to Dr. Davidson's website

Frequently Asked Questions
Review the answers to the most commonly asked questions about Clearant and the Clearant Process®

Contact Information
Contact us for more information about becoming a client licensee of the Clearant Process® .